The funding will be used to expand the firm's global services, enhance its core platforms, and accelerate the development of pathology foundational models.

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

FDA officials said that the draft guidance is meant to address recommendations from two reports on the agency's response to COVID-19.

The government alleges Labcorp and UHS delayed submission of orders for tests by Caris Life Sciences to enable improper billings to Medicare for those tests.

Firms in the space advanced solutions to stratify sepsis patients and accelerated time-to-results to find out the cause of infections.

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

The firm received notice that it had failed to regain compliance with the Nasdaq's requirement to maintain a minimum $35 million market value of listed securities.

The Nova Scotia-based firm's Multiplo Rapid TP/HIV Test is used to detect antibodies to HIV 1/2 and syphilis in a finger prick blood sample.

Rapid Health allegedly submitted false claims to Medicare for over-the-counter COVID-19 tests that were not provided to Medicare beneficiaries.

Foresight said Roche failed to bring its trade-secret causes of action within the three-year statute of limitations.

The TissueCypher assay is designed to identify patients with Barrett's esophagus who are at risk of progressing to esophageal cancer.

Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.